Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Amortization of Deferred Charges: 2011-2025

Historic Amortization of Deferred Charges for Mimedx Group (MDXG) over the last 10 years, with Mar 2025 value amounting to $135,000.

  • Mimedx Group's Amortization of Deferred Charges rose 95.65% to $135,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $464,000, marking a year-over-year increase of 2.43%. This contributed to the annual value of $505,000 for FY2023, which is 8.14% up from last year.
  • As of Q1 2025, Mimedx Group's Amortization of Deferred Charges stood at $135,000, which was up 95.65% from $69,000 recorded in Q1 2024.
  • Mimedx Group's Amortization of Deferred Charges' 5-year high stood at $418,000 during Q2 2021, with a 5-year trough of $69,000 in Q1 2024.
  • In the last 3 years, Mimedx Group's Amortization of Deferred Charges had a median value of $126,000 in 2023 and averaged $118,167.
  • Within the past 5 years, the most significant YoY rise in Mimedx Group's Amortization of Deferred Charges was 109.00% (2021), while the steepest drop was 75.91% (2021).
  • Over the past 5 years, Mimedx Group's Amortization of Deferred Charges (Quarterly) stood at $112,000 in 2021, then rose by 6.25% to $119,000 in 2022, then increased by 10.92% to $132,000 in 2023, then slumped by 42.98% to $69,000 in 2024, then skyrocketed by 95.65% to $135,000 in 2025.
  • Its last three reported values are $135,000 in Q1 2025, $69,000 for Q1 2024, and $132,000 during Q4 2023.